{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:04:33Z","timestamp":1790201073111,"version":"4.1.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00210-025-04887-1","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T07:10:48Z","timestamp":1767424248000},"page":"7741-7762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in understanding, diagnosing, and treating hepatic encephalopathy: from epidemiology to emerging therapies"],"prefix":"10.1007","volume":"399","author":[{"given":"Sunny","family":"Rathee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"46","key":"4887_CR1","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1002\/adfm.201603519","volume":"26","author":"V Agostoni","year":"2016","unstructured":"Agostoni V, Lee SH, Forster V, Kabbaj M, Bosoi CR, Tremblay M et al (2016) Liposome-supported peritoneal dialysis for the treatment of hyperammonemia-associated encephalopathy. Adv Funct Mater 26(46):8382\u20138389","journal-title":"Adv Funct Mater"},{"key":"4887_CR2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jsbmb.2015.08.020","volume":"160","author":"A Agusti","year":"2016","unstructured":"Agusti A, Llansola M, Hern\u00e1ndez-Rabaza V, Cabrera-Pastor A, Montoliu C, Felipo V (2016) Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy. J Steroid Biochem Mol Biol 160:88\u201393","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4887_CR3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11011-007-9065-2","volume":"22","author":"S Ahboucha","year":"2007","unstructured":"Ahboucha S, Butterworth RF (2007) The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab Brain Dis 22:291\u2013308","journal-title":"Metab Brain Dis"},{"issue":"4","key":"4887_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuint.2006.02.002","volume":"49","author":"S Ahboucha","year":"2006","unstructured":"Ahboucha S, Pomier-Layrargues G, Mamer O, Butterworth RF (2006) Increased levels of pregnenolone and its neuroactive metabolite allopregnanolone in autopsied brain tissue from cirrhotic patients who died in hepatic coma. Neurochem Int 49(4):372\u2013378","journal-title":"Neurochem Int"},{"issue":"1","key":"4887_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.07.033","volume":"62","author":"V Ahluwalia","year":"2015","unstructured":"Ahluwalia V, Heuman DM, Feldman G, Wade JB, Thacker LR, Gavis E et al (2015) Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis. J Hepatol 62(1):75\u201382","journal-title":"J Hepatol"},{"key":"4887_CR6","volume":"2","author":"B Als-Nielsen","year":"2003","unstructured":"Als-Nielsen B, Koretz RL, Kjaergard L, Gluud C (2003) Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev 2:CD001939-CD","journal-title":"Cochrane Database Syst Rev"},{"key":"4887_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.03.006","volume":"60","author":"A Altamirano-Barrera","year":"2018","unstructured":"Altamirano-Barrera A, Uribe M, Ch\u00e1vez-Tapia NC, Nu\u00f1o-L\u00e1mbarri N (2018) The role of the gut microbiota in the pathology and prevention of liver disease. J Nutr Biochem 60:1\u20138","journal-title":"J Nutr Biochem"},{"issue":"1","key":"4887_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.26370","volume":"58","author":"P Amodio","year":"2013","unstructured":"Amodio P, Bemeur C, Butterworth R, Cordoba J, Kato A, Montagnese S et al (2013) The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology 58(1):325\u2013336","journal-title":"Hepatology"},{"issue":"5","key":"4887_CR9","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11050837","volume":"11","author":"A Arjunan","year":"2022","unstructured":"Arjunan A, Sah DK, Jung YD, Song J (2022) Hepatic encephalopathy and melatonin. Antioxidants 11(5):837","journal-title":"Antioxidants"},{"key":"4887_CR10","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135(5):1591\u2013600. e1","DOI":"10.1053\/j.gastro.2008.07.021"},{"issue":"4","key":"4887_CR11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.23128","volume":"50","author":"JS Bajaj","year":"2009","unstructured":"Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR et al (2009) Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50(4):1175\u20131183","journal-title":"Hepatology"},{"issue":"3","key":"4887_CR12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.26309","volume":"58","author":"JS Bajaj","year":"2013","unstructured":"Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ et al (2013) The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology 58(3):1122\u20131132","journal-title":"Hepatology"},{"issue":"6","key":"4887_CR13","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"Bajaj JS, Kassam Z, Fagan A, Gavis EA, Liu E, Cox IJ et al (2017) Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology 66(6):1727\u20131738","journal-title":"Hepatology"},{"key":"4887_CR14","unstructured":"Banerjee S (2023) Role of micronutrients in brain pathology, Micronutrients and the Human Brain 6:341"},{"issue":"7","key":"4887_CR15","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1523\/JNEUROSCI.08-07-02414.1988","volume":"8","author":"A Basile","year":"1988","unstructured":"Basile A, Gammal S, Mullen K, Jones E, Skolnick P (1988) Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy. J Neurosci 8(7):2414\u20132421","journal-title":"J Neurosci"},{"issue":"7","key":"4887_CR16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199108153250705","volume":"325","author":"AS Basile","year":"1991","unstructured":"Basile AS, Hughes RD, Harrison PM, Murata Y, Pannell L, Jones EA et al (1991) Elevated brain concentrations of 1, 4-benzodiazepines in fulminant hepatic failure. N Engl J Med 325(7):473\u2013478","journal-title":"N Engl J Med"},{"key":"4887_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1746-6342.2006.03218.x","volume":"25","author":"N Bass","year":"2007","unstructured":"Bass N (2007) The current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 25:23\u201331","journal-title":"Aliment Pharmacol Ther"},{"key":"4887_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11011-010-9177-y","volume":"25","author":"C Bemeur","year":"2010","unstructured":"Bemeur C, Desjardins P, Butterworth RF (2010) Evidence for oxidative\/nitrosative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 25:3\u20139","journal-title":"Metab Brain Dis"},{"issue":"5","key":"4887_CR19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<673::AID-JNR12>3.0.CO;2-P","volume":"54","author":"AS Bender","year":"1998","unstructured":"Bender AS, Norenberg MD (1998) Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J Neurosci Res 54(5):673\u2013680","journal-title":"J Neurosci Res"},{"key":"4887_CR20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF00964814","volume":"14","author":"M Bergeron","year":"1989","unstructured":"Bergeron M, Reader TA, Layrargues GP, Butterworth RF (1989) Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochem Res 14:853\u2013859","journal-title":"Neurochem Res"},{"issue":"1","key":"4887_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/jcm4010085","volume":"4","author":"M Bernardi","year":"2014","unstructured":"Bernardi M, Ricci CS, Santi L (2014) Hyponatremia in patients with cirrhosis of the liver. J Clin Med 4(1):85\u2013101","journal-title":"J Clin Med"},{"issue":"1","key":"4887_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/17474930211073387","volume":"18","author":"JM Biesbroek","year":"2023","unstructured":"Biesbroek JM, Biessels GJ (2023) Diagnosing vascular cognitive impairment: current challenges and future perspectives. Int J Stroke 18(1):36\u201343","journal-title":"Int J Stroke"},{"key":"4887_CR23","volume-title":"Practical neurology","author":"J Biller","year":"2012","unstructured":"Biller J (2012) Practical neurology. Lippincott Williams & Wilkins"},{"issue":"1","key":"4887_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MEG.0b013e3283417567","volume":"23","author":"M Bismuth","year":"2011","unstructured":"Bismuth M, Funakoshi N, Cadranel J-F, Blanc P (2011) Hepatic encephalopathy: from pathophysiology to therapeutic management. Eur J Gastroenterol Hepatol 23(1):8\u201322","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"4887_CR25","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.24273","volume":"53","author":"CR Bosoi","year":"2011","unstructured":"Bosoi CR, Parent-Robitaille C, Anderson K, Tremblay M, Rose CF (2011) AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct\u2013ligated rats. Hepatology 53(6):1995\u20132002","journal-title":"Hepatology"},{"issue":"7","key":"4887_CR26","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.freeradbiomed.2012.01.006","volume":"52","author":"CR Bosoi","year":"2012","unstructured":"Bosoi CR, Yang X, Huynh J, Parent-Robitaille C, Jiang W, Tremblay M et al (2012) Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure. Free Radic Biol Med 52(7):1228\u20131235","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"4887_CR27","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/jgh.14558","volume":"34","author":"L Bossen","year":"2019","unstructured":"Bossen L, Gin\u00e8s P, Vilstrup H, Watson H, Jepsen P (2019) Serum sodium as a risk factor for hepatic encephalopathy in patients with cirrhosis and ascites. J Gastroenterol Hepatol 34(5):914\u2013920","journal-title":"J Gastroenterol Hepatol"},{"key":"4887_CR28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF01307722","volume":"37","author":"RF Butterworth","year":"1992","unstructured":"Butterworth RF (1992) Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37:321\u2013327","journal-title":"Dig Dis Sci"},{"key":"4887_CR29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.11.006","volume":"160","author":"RF Butterworth","year":"2016","unstructured":"Butterworth RF (2016) Neurosteroids in hepatic encephalopathy: novel insights and new therapeutic opportunities. J Steroid Biochem Mol Biol 160:94\u201397","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4887_CR30","doi-asserted-by":"crossref","unstructured":"Butterworth RF (2020) Hepatic encephalopathy. The liver: biology and pathobiology, pp 615\u2013629","DOI":"10.1002\/9781119436812.ch48"},{"issue":"5","key":"4887_CR31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840080517","volume":"8","author":"RF Butterworth","year":"1988","unstructured":"Butterworth RF, Lavoie J, Gigu\u00e8re JF, Pomier-Layrargues G (1988) Affinities and densities of high-affinity [3H] muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology 8(5):1084\u20131088","journal-title":"Hepatology"},{"issue":"1","key":"4887_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","volume":"66","author":"F Campagna","year":"2017","unstructured":"Campagna F, Montagnese S, Ridola L, Senzolo M, Schiff S, De Rui M et al (2017) The animal naming test: an easy tool for the assessment of hepatic encephalopathy. Hepatology 66(1):198\u2013208","journal-title":"Hepatology"},{"issue":"10138","key":"4887_CR33","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni P, Riggio O, Angeli P, Alessandria C, Neri S, Foschi FG et al (2018) Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet 391(10138):2417\u20132429","journal-title":"Lancet"},{"issue":"1","key":"4887_CR34","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/ijms21010294","volume":"21","author":"A Chagraoui","year":"2019","unstructured":"Chagraoui A, Boulain M, Juvin L, Anouar Y, Barri\u00e8re G, De Deurwaerd\u00e8re P (2019) L-DOPA in parkinson\u2019s disease: looking at the \u201cfalse\u201d neurotransmitters and their meaning. Int J Mol Sci 21(1):294","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4887_CR35","first-page":"1","volume":"12","author":"NC Chavez-Tapia","year":"2013","unstructured":"Chavez-Tapia NC, Cesar-Arce A, Barrientos-Guti\u00e9rrez T, Villegas-L\u00f3pez FA, M\u00e9ndez-Sanchez N, Uribe M (2013) A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy. Nutr J 12(1):1\u20136","journal-title":"Nutr J"},{"issue":"3","key":"4887_CR36","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JY Chiang","year":"2020","unstructured":"Chiang JY, Ferrell JM (2020) Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol 318(3):G554\u2013G573","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4887_CR37","volume":"164","author":"J Chu","year":"2023","unstructured":"Chu J, Feng S, Guo C, Xue B, He K, Li L (2023) Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: a review. Biomed Pharmacother 164:114985","journal-title":"Biomed Pharmacother"},{"key":"4887_CR38","unstructured":"Clark M (2022) Brain and behaviour: molecular mechanisms of neurotransmission and their role in disorder, pp 1\u2013100"},{"issue":"5","key":"4887_CR39","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0168-8278(01)00181-7","volume":"35","author":"J C\u00f3rdoba","year":"2001","unstructured":"C\u00f3rdoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells Ls et al (2001) The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation. J Hepatol 35(5):598\u2013604","journal-title":"J Hepatol"},{"key":"4887_CR40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11011-010-9172-3","volume":"25","author":"J C\u00f3rdoba","year":"2010","unstructured":"C\u00f3rdoba J, Garc\u00eda-Martinez R, Sim\u00f3n-Talero M (2010) Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Metab Brain Dis 25:73\u201380","journal-title":"Metab Brain Dis"},{"issue":"2","key":"4887_CR41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","volume":"60","author":"J Cordoba","year":"2014","unstructured":"Cordoba J, Ventura-Cots M, Sim\u00f3n-Talero M, Amor\u00f3s \u00c0, Pavesi M, Vilstrup H et al (2014) Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 60(2):275\u2013281","journal-title":"J Hepatol"},{"issue":"5","key":"4887_CR42","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.10045","volume":"66","author":"P Desjardins","year":"2001","unstructured":"Desjardins P, B\u00e9langer M, Butterworth RF (2001) Alterations in expression of genes coding for key astrocytic proteins in acute liver failure. J Neurosci Res 66(5):967\u2013971","journal-title":"J Neurosci Res"},{"key":"4887_CR43","doi-asserted-by":"crossref","unstructured":"Di Pascoli M, Ceranto E, De Nardi P, Donato D, Gatta A, Angeli P et al (2017) Hospitalizations due to cirrhosis: clinical aspects in a large cohort of Italian patients and cost analysis report. Dig Dis 35(5):433\u2013438","DOI":"10.1159\/000458722"},{"key":"4887_CR44","unstructured":"Djebaili R (2022) Structure-activity approaches for prediction of chemical reactivity and pharmacological properties of some heterocyclic compounds: Universit\u00e9 de mohamedkheiderbiskra"},{"key":"4887_CR45","unstructured":"Driver RJ (2022) Understanding outcomes in hepatocellular carcinoma and cirrhosis in England: University of Leeds"},{"key":"4887_CR46","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00018.2001","author":"W Dr\u00f6ge","year":"2002","unstructured":"Dr\u00f6ge W (2002) Free radicals in the physiological control of cell function. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00018.2001","journal-title":"Physiol Rev"},{"issue":"5","key":"4887_CR47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000524400","volume":"91","author":"SL Dubovsky","year":"2022","unstructured":"Dubovsky SL, Marshall D (2022) Benzodiazepines remain important therapeutic options in psychiatric practice. Psychother Psychosom 91(5):307\u2013334","journal-title":"Psychother Psychosom"},{"issue":"12","key":"4887_CR48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1080\/14712598.2019.1673725","volume":"19","author":"A Elangovan","year":"2019","unstructured":"Elangovan A, Allegretti JR, Fischer M (2019) Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opin Biol Ther 19(12):1343\u20131355","journal-title":"Expert Opin Biol Ther"},{"key":"4887_CR49","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000159","author":"N Fabrellas","year":"2020","unstructured":"Fabrellas N, Moreira R, Carol M, Cervera M, de Prada G, Perez M et al (2020) Psychological burden of hepatic encephalopathy on patients and caregivers. Clin Transl Gastroenterol. https:\/\/doi.org\/10.14309\/ctg.0000000000000159","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"4887_CR50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1362-1017.2006.00149.x","volume":"11","author":"V Faint","year":"2006","unstructured":"Faint V (2006) The pathophysiology of hepatic encephalopathy. Nurs Crit Care 11(2):69\u201374","journal-title":"Nurs Crit Care"},{"issue":"2","key":"4887_CR51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/gastro\/gox013","volume":"5","author":"P Ferenci","year":"2017","unstructured":"Ferenci P (2017) Hepatic encephalopathy. Gastroenterol Rep 5(2):138\u2013147","journal-title":"Gastroenterol Rep"},{"key":"4887_CR52","doi-asserted-by":"crossref","unstructured":"Ferenci P (2007) Treatment options for hepatic encephalopathy: a review.\u00a0Semin Liver Dis","DOI":"10.1055\/s-2007-984574"},{"issue":"7715","key":"4887_CR53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(71)92048-4","volume":"298","author":"J Fischer","year":"1971","unstructured":"Fischer J, Baldessarini R (1971) False neurotransmitters and hepatic failure. Lancet 298(7715):75\u201380","journal-title":"Lancet"},{"issue":"12","key":"4887_CR54","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3390\/jcm9124049","volume":"9","author":"KD Galsgaard","year":"2020","unstructured":"Galsgaard KD (2020) The vicious circle of hepatic glucagon resistance in non-alcoholic fatty liver disease. J Clin Med 9(12):4049","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"4887_CR55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40261-022-01146-6","volume":"42","author":"R Garc\u00eda-Mart\u00ednez","year":"2022","unstructured":"Garc\u00eda-Mart\u00ednez R, Diaz-Ruiz R, Poncela M (2022) Management of hepatic encephalopathy associated with advanced liver disease. Clin Drug Investig 42(Suppl 1):5\u201313","journal-title":"Clin Drug Investig"},{"issue":"1","key":"4887_CR56","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/hep.23656","volume":"52","author":"B G\u00f6rg","year":"2010","unstructured":"G\u00f6rg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K et al (2010) Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 52(1):256\u2013265","journal-title":"Hepatology"},{"key":"4887_CR57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12072-017-9812-3","volume":"12","author":"A Hadjihambi","year":"2018","unstructured":"Hadjihambi A, Arias N, Sheikh M, Jalan R (2018) Hepatic encephalopathy: a critical current review. Hepatol Int 12:135\u2013147","journal-title":"Hepatol Int"},{"issue":"1","key":"4887_CR58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.28852","volume":"65","author":"TB Hakvoort","year":"2017","unstructured":"Hakvoort TB, He Y, Kulik W, Vermeulen JL, Duijst S, Ruijter JM et al (2017) Pivotal role of glutamine synthetase in ammonia detoxification. Hepatology 65(1):281\u2013293","journal-title":"Hepatology"},{"key":"4887_CR59","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jss.2018.11.047","volume":"236","author":"T Hata","year":"2019","unstructured":"Hata T, Rehman F, Hori T, Nguyen JH (2019) GABA, \u03b3-aminobutyric acid, protects against severe liver injury. J Surg Res 236:172\u2013183","journal-title":"J Surg Res"},{"key":"4887_CR60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lfs.2018.12.030","volume":"218","author":"R Heidari","year":"2019","unstructured":"Heidari R (2019) Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sci 218:65\u201380","journal-title":"Life Sci"},{"issue":"2","key":"4887_CR61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0009-8981(71)90331-7","volume":"32","author":"C Hirayama","year":"1971","unstructured":"Hirayama C (1971) Tryptophan metabolism in liver disease. Clin Chim Acta 32(2):191\u2013197","journal-title":"Clin Chim Acta"},{"issue":"23","key":"4887_CR62","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.2174\/1381612821666150619092720","volume":"21","author":"G Hulse","year":"2015","unstructured":"Hulse G, Kelty E, Hood S, Norman A, Rita Basso M, Stuart Reece A (2015) Novel indications for benzodiazepine antagonist flumazenil in GABA mediated pathological conditions of the central nervous system. Curr Pharm des 21(23):3325\u20133342","journal-title":"Curr Pharm des"},{"issue":"5","key":"4887_CR63","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.mehy.2006.12.061","volume":"69","author":"R Jalan","year":"2007","unstructured":"Jalan R, Wright G, Davies N, Hodges S (2007) L-ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 69(5):1064\u20131069","journal-title":"Med Hypotheses"},{"issue":"3","key":"4887_CR64","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jceh.2018.06.007","volume":"8","author":"A Jayakumar","year":"2018","unstructured":"Jayakumar A, Norenberg MD (2018) Hyperammonemia in hepatic encephalopathy. J Clin Exp Hepatol 8(3):272\u2013280","journal-title":"J Clin Exp Hepatol"},{"key":"4887_CR65","unstructured":"Jia Y (2019) Forms of supplemental selenium in vitamin-mineral mixes differentially affect serological and hepatic parameters of growing beef steers grazing endophyte-infected tall fescue, pp\u00a01\u2014332"},{"issue":"5","key":"4887_CR66","doi-asserted-by":"crossref","first-page":"G400","DOI":"10.1152\/ajpgi.00073.2015","volume":"309","author":"M Johansson","year":"2015","unstructured":"Johansson M, Agusti A, Llansola M, Montoliu C, Str\u00f6mberg J, Malinina E et al (2015) GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 309(5):G400\u2013G409","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4887_CR67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jsbmb.2015.10.019","volume":"160","author":"M Johansson","year":"2016","unstructured":"Johansson M, Str\u00f6mberg J, Ragagnin G, Doverskog M, B\u00e4ckstr\u00f6m T (2016) GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo. J Steroid Biochem Mol Biol 160:98\u2013105","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"4887_CR68","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1212\/01.WNL.0000167411.93483.A1","volume":"64","author":"K Josephs","year":"2005","unstructured":"Josephs K, Ahlskog J, Klos K, Kumar N, Fealey R, Trenerry M et al (2005) Neurologic manifestations in welders with pallidal MRI T1 hyperintensity. Neurology 64(12):2033\u20132039","journal-title":"Neurology"},{"issue":"3","key":"4887_CR69","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jhep.2013.10.012","volume":"60","author":"M Jover-Cobos","year":"2014","unstructured":"Jover-Cobos M, Noiret L, Lee K, Sharma V, Habtesion A, Romero-Gomez M et al (2014) Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats. J Hepatol 60(3):545\u2013553","journal-title":"J Hepatol"},{"issue":"3","key":"4887_CR70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccc.2016.03.001","volume":"32","author":"PA Kandiah","year":"2016","unstructured":"Kandiah PA, Kumar G (2016) Hepatic encephalopathy\u2014the old and the new. Crit Care Clin 32(3):311\u2013329","journal-title":"Crit Care Clin"},{"issue":"1","key":"4887_CR71","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.28121","volume":"63","author":"D Kao","year":"2016","unstructured":"Kao D, Roach B, Park H, Hotte N, Madsen K, Bain V et al (2016) Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology 63(1):339\u2013340","journal-title":"Hepatology"},{"key":"4887_CR72","first-page":"457","volume":"1","author":"M Kd","year":"1988","unstructured":"Kd M (1988) Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy. Lancet 1:457\u2013459","journal-title":"Lancet"},{"issue":"1","key":"4887_CR73","volume":"2016","author":"A Khan","year":"2016","unstructured":"Khan A, Ayub M, Khan WM (2016) Hyperammonemia is associated with increasing severity of both liver cirrhosis and hepatic encephalopathy. Int J Hepatol 2016(1):6741754","journal-title":"Int J Hepatol"},{"key":"4887_CR74","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1046\/j.1440-1746.17.s3.11.x","volume":"17","author":"G Kircheis","year":"2002","unstructured":"Kircheis G, H\u00e4ussinger D (2002) Management of hepatic encephalopathy. J Gastroenterol Hepatol 17:S260\u2013S267","journal-title":"J Gastroenterol Hepatol"},{"issue":"10","key":"4887_CR75","doi-asserted-by":"crossref","first-page":"G1024","DOI":"10.1152\/ajpgi.00244.2014","volume":"307","author":"RG Kristiansen","year":"2014","unstructured":"Kristiansen RG, Rose CF, Fuskev\u00e5g O-M, M\u00e6hre H, Revhaug A, Jalan R et al (2014) L-ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway. Am J Physiol Gastrointest Liver Physiol 307(10):G1024\u2013G1031","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4887_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114696","volume":"649","author":"K Kroupina","year":"2022","unstructured":"Kroupina K, B\u00e9meur C, Rose CF (2022) Amino acids, ammonia, and hepatic encephalopathy. Anal Biochem 649:114696","journal-title":"Anal Biochem"},{"key":"4887_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/bbb\/zbae066","author":"T Kumrungsee","year":"2024","unstructured":"Kumrungsee T (2024) Is hepatic GABA transaminase a promising target for obesity and epilepsy treatments? Biosci Biotechnol Biochem. https:\/\/doi.org\/10.1093\/bbb\/zbae066","journal-title":"Biosci Biotechnol Biochem"},{"issue":"475","key":"4887_CR78","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7975","volume":"11","author":"CB Kurtz","year":"2019","unstructured":"Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM et al (2019) An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med 11(475):eaau7975","journal-title":"Sci Transl Med"},{"key":"4887_CR79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11011-012-9373-z","volume":"28","author":"MM Lauridsen","year":"2013","unstructured":"Lauridsen MM, Thiele M, Kimer N, Vilstrup H (2013) The continuous reaction times method for diagnosing, grading, and monitoring minimal\/covert hepatic encephalopathy. Metab Brain Dis 28:231\u2013234","journal-title":"Metab Brain Dis"},{"issue":"2","key":"4887_CR80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/nu10020140","volume":"10","author":"J Liu","year":"2018","unstructured":"Liu J, Lkhagva E, Chung H-J, Kim H-J, Hong S-T (2018) The pharmabiotic approach to treat hyperammonemia. Nutrients 10(2):140","journal-title":"Nutrients"},{"key":"4887_CR81","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev-pharmtox-010919-023628","volume":"60","author":"C Long-Smith","year":"2020","unstructured":"Long-Smith C, O\u2019Riordan KJ, Clarke G, Stanton C, Dinan TG, Cryan JF (2020) Microbiota-gut-brain axis: new therapeutic opportunities. Annu Rev Pharmacol Toxicol 60:477\u2013502","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"4887_CR82","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5152\/tjg.2019.18226","volume":"30","author":"M Luo","year":"2019","unstructured":"Luo M, Ma P, Li L, Cao W-K (2019) Advances in psychometric tests for screening minimal hepatic encephalopathy: from paper-and-pencil to computer-aided assessment. Turk J Gastroenterol 30(5):398","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"4887_CR83","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1039\/C7FO01528C","volume":"9","author":"A Mancini","year":"2018","unstructured":"Mancini A, Campagna F, Amodio P, Tuohy KM (2018) Gut: liver: brain axis: the microbial challenge in the hepatic encephalopathy. Food Funct 9(3):1373\u20131388","journal-title":"Food Funct"},{"issue":"9","key":"4887_CR84","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/ajg.2011.123","volume":"106","author":"C Montoliu","year":"2011","unstructured":"Montoliu C, Cauli O, Urios A, ElMlili N, Serra MA, Giner-Duran R et al (2011) 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 106(9):1629\u20131637","journal-title":"Am J Gastroenterol"},{"issue":"8707","key":"4887_CR85","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0140-6736(90)91594-Z","volume":"336","author":"K Mullen","year":"1990","unstructured":"Mullen K, Szauter K, Kaminsky-Russ K (1990) \u201cEndogenous\u201d benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336(8707):81\u201383","journal-title":"Lancet"},{"issue":"4","key":"4887_CR86","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.29369","volume":"66","author":"BH Mullish","year":"2017","unstructured":"Mullish BH, McDonald JA, Thursz MR, Marchesi JR (2017) Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology 66(4):1354\u20131355","journal-title":"Hepatology"},{"issue":"3","key":"4887_CR87","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/17474124.2023.2183386","volume":"17","author":"S Nardelli","year":"2023","unstructured":"Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L (2023) Hepatic encephalopathy\u2013recent advances in treatment and diagnosis. Expert Rev Gastroenterol Hepatol 17(3):225\u2013235","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"4887_CR88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2016.04.009","volume":"111","author":"R Nardone","year":"2016","unstructured":"Nardone R, Taylor AC, H\u00f6ller Y, Brigo F, Lochner P, Trinka E (2016) Minimal hepatic encephalopathy: a review. Neurosci Res 111:1\u201312","journal-title":"Neurosci Res"},{"issue":"9","key":"4887_CR89","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.dld.2016.06.014","volume":"48","author":"V Nicoletti","year":"2016","unstructured":"Nicoletti V, Gioia S, Lucatelli P, Nardelli S, Pasquale C, Sobrinho SN et al (2016) Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: description, prevalence and risk factors. Dig Liver Dis 48(9):1072\u20131077","journal-title":"Dig Liver Dis"},{"key":"4887_CR90","unstructured":"Nilsson E (2019) Liver cirrhosis in southern Sweden. Epidemiology and clinical course, Doctoral dissertation, Lund University, pp 1\u201382"},{"issue":"11","key":"4887_CR91","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/apt.15255","volume":"49","author":"E Nilsson","year":"2019","unstructured":"Nilsson E, Anderson H, Sargenti K, Lindgren S, Prytz H (2019) Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients. Aliment Pharmacol Ther 49(11):1421\u20131430","journal-title":"Aliment Pharmacol Ther"},{"key":"4887_CR92","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-10-7425-7","volume-title":"Clinical investigation of portal hypertension","author":"K Obara","year":"2019","unstructured":"Obara K, Kage M, Murashima N (2019) Clinical investigation of portal hypertension. Springer"},{"issue":"1","key":"4887_CR93","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jhep.2011.06.026","volume":"56","author":"M Oria","year":"2012","unstructured":"Oria M, Romero-Gim\u00e9nez J, Arranz JA, Riudor E, Raguer N, C\u00f3rdoba J (2012) Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis. J Hepatol 56(1):109\u2013114","journal-title":"J Hepatol"},{"key":"4887_CR94","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s11011-015-9743-4","volume":"31","author":"VC Patel","year":"2016","unstructured":"Patel VC, White H, St\u00f8y S, Bajaj JS, Shawcross DL (2016) Clinical science workshop: targeting the gut-liver-brain axis. Metab Brain Dis 31:1327\u20131337","journal-title":"Metab Brain Dis"},{"issue":"3","key":"4887_CR95","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","volume":"69","author":"L Pimpin","year":"2018","unstructured":"Pimpin L, Cortez-Pinto H, Negro F, Corbould E, Lazarus JV, Webber L et al (2018) Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies. J Hepatol 69(3):718\u2013735","journal-title":"J Hepatol"},{"issue":"2","key":"4887_CR96","first-page":"135","volume":"24","author":"MO Qureshi","year":"2014","unstructured":"Qureshi MO, Khokhar N, Saleem A, Niazi TK (2014) Correlation of hyponatremia with hepatic encephalopathy and severity of liver disease. J Coll Physicians Surg Pak 24(2):135\u2013137","journal-title":"J Coll Physicians Surg Pak"},{"issue":"17","key":"4887_CR97","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1073\/pnas.1423968112","volume":"112","author":"N Qvartskhava","year":"2015","unstructured":"Qvartskhava N, Lang PA, G\u00f6rg B, Pozdeev VI, Ortiz MP, Lang KS et al (2015) Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase. Proc Natl Acad Sci U S A 112(17):5521\u20135526","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4887_CR98","volume":"31","author":"L Ridola","year":"2018","unstructured":"Ridola L, Cardinale V, Riggio O (2018) The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. Ann Gastroenterol 31(2):151","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"4887_CR99","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2478\/jtim-2020-0034","volume":"8","author":"L Ridola","year":"2020","unstructured":"Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O (2020) Hepatic encephalopathy: diagnosis and management. J Transl Intern Med 8(4):210\u2013219","journal-title":"J Transl Intern Med"},{"key":"4887_CR100","unstructured":"Rissardo JP, Khalil I, Sayad R, Kedwany AM, Sayed HH, Chouthai AA, Caprara AL (2025) A narrative review of minimal hepatic encephalopathy, pp 1\u201346"},{"issue":"3","key":"4887_CR101","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/hep.26611","volume":"59","author":"DC Rockey","year":"2014","unstructured":"Rockey DC, Vierling JM, Mantry P, Ghabril M, Brown RS Jr, Alexeeva O et al (2014) Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology 59(3):1073\u20131083","journal-title":"Hepatology"},{"issue":"3","key":"4887_CR102","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.2012.112","volume":"92","author":"CF Rose","year":"2012","unstructured":"Rose CF (2012) Ammonia-lowering strategies for the treatment of hepatic encephalopathy. Clin Pharmacol Ther 92(3):321\u2013331","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"4887_CR103","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","volume":"73","author":"CF Rose","year":"2020","unstructured":"Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD et al (2020) Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol 73(6):1526\u20131547","journal-title":"J Hepatol"},{"issue":"2","key":"4887_CR104","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cld.2021.01.008","volume":"25","author":"M Rudler","year":"2021","unstructured":"Rudler M, Weiss N, Bouzbib C, Thabut D (2021) Diagnosis and management of hepatic encephalopathy. Clin Liver Dis 25(2):393\u2013417","journal-title":"Clin Liver Dis"},{"key":"4887_CR105","unstructured":"Safadi R, Rahimi RS, DiLiberti CE, Wang L, Pyrsopoulos NT, Potthoff A et al (2017) OCR-002 (ornithine phenylacetate) is a potent ammonia scavenger as demonstrated in phase 2b stop-he study. Hepatology, Wiley 111 River ST, Hoboken, NJ, USA, pp\u00a007030\u20135774"},{"issue":"6","key":"4887_CR106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.12968\/bjon.2007.16.6.23003","volume":"16","author":"S Sargent","year":"2007","unstructured":"Sargent S (2007) Pathophysiology and management of hepatic encephalopathy. Br J Nurs 16(6):335\u2013339","journal-title":"Br J Nurs"},{"issue":"9","key":"4887_CR107","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1535370221989263","volume":"246","author":"SM Sears","year":"2021","unstructured":"Sears SM, Hewett SJ (2021) Influence of glutamate and GABA transport on brain excitatory\/inhibitory balance. Exp Biol Med 246(9):1069\u20131083","journal-title":"Exp Biol Med"},{"issue":"1","key":"4887_CR108","volume":"25","author":"BK Sen","year":"2025","unstructured":"Sen BK, Pan K, Chakravarty A (2025) Hepatic encephalopathy: current thoughts on pathophysiology and management. Curr Neurol Neurosci Rep 25(1):28","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"27","key":"4887_CR109","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v16.i27.3347","volume":"16","author":"AS Seyan","year":"2010","unstructured":"Seyan AS, Hughes RD, Shawcross DL (2010) Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol: WJG 16(27):3347","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"4887_CR110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2007.02.022","volume":"47","author":"P Sharma","year":"2007","unstructured":"Sharma P, Sharma B, Puri V, Sarin S (2007) Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 47(1):67\u201373","journal-title":"J Hepatol"},{"issue":"6","key":"4887_CR111","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jgh.13666","volume":"32","author":"BC Sharma","year":"2017","unstructured":"Sharma BC, Singh J, Srivastava S, Sangam A, Mantri AK, Trehanpati N et al (2017) Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. J Gastroenterol Hepatol 32(6):1234\u20131239","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"4887_CR112","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jhep.2010.07.045","volume":"54","author":"D Shawcross","year":"2011","unstructured":"Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N et al (2011) Infection and systemic inflammation, not ammonia, are associated with grade 3\/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol 54(4):640\u2013649","journal-title":"J Hepatol"},{"issue":"1","key":"4887_CR113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jceh.2019.06.002","volume":"10","author":"D Shrestha","year":"2020","unstructured":"Shrestha D, Rathi S, Grover S, Taneja S, Duseja A, Chawla YK et al (2020) Factors affecting psychological burden on the informal caregiver of patients with cirrhosis: looking beyond the patient. J Clin Exp Hepatol 10(1):9\u201316","journal-title":"J Clin Exp Hepatol"},{"key":"4887_CR114","doi-asserted-by":"crossref","unstructured":"Takikawa Y, Kuroda H, Sawara K (2016) The brain and liver. The liver in systemic diseases, pp 51\u201375","DOI":"10.1007\/978-4-431-55790-6_4"},{"issue":"3","key":"4887_CR115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.55544\/jrasb.3.3.27","volume":"3","author":"S Tejpal","year":"2024","unstructured":"Tejpal S, Sharma SK, Sharma A, Sharma S (2024) A comprehensive review on hepatic encephalopathy: pathophysiology, symptoms, epidemiology, classification, diagnosis and treatment. Journal for Research in Applied Sciences and Biotechnology 3(3):170\u2013180","journal-title":"Journal for Research in Applied Sciences and Biotechnology"},{"key":"4887_CR116","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2022.100757","author":"P Vidal-Cevallos","year":"2022","unstructured":"Vidal-Cevallos P, Ch\u00e1vez-Tapia NC, Uribe M (2022) Current approaches to hepatic encephalopathy. Ann Hepatol. https:\/\/doi.org\/10.1016\/j.aohep.2022.100757","journal-title":"Ann Hepatol"},{"issue":"2","key":"4887_CR117","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD et al (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology 60(2):715\u2013735","journal-title":"Hepatology"},{"issue":"2","key":"4887_CR118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/14728222.2017.1272581","volume":"21","author":"K Wal\u00f8en","year":"2017","unstructured":"Wal\u00f8en K, Kleppe R, Martinez A, Haavik J (2017) Tyrosine and tryptophan hydroxylases as therapeutic targets in human disease. Expert Opin Ther Targets 21(2):167\u2013180","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"4887_CR119","volume":"2020","author":"S-Z Wan","year":"2020","unstructured":"Wan S-Z, Nie Y, Zhang Y, Liu C, Zhu X (2020) [Retracted] Assessing the prognostic performance of the Child\u2010Pugh, Model for End\u2010Stage Liver Disease, and Albumin\u2010Bilirubin Scores in patients with decompensated cirrhosis: a large asian cohort from Gastroenterology Department. Dis Markers 2020(1):5193028","journal-title":"Dis Markers"},{"key":"4887_CR120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11011-013-9384-4","volume":"28","author":"H Watson","year":"2013","unstructured":"Watson H, Jepsen P, Wong F, Gin\u00e8s P, C\u00f3rdoba J, Vilstrup H (2013) Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development. Metab Brain Dis 28:301\u2013305","journal-title":"Metab Brain Dis"},{"issue":"11","key":"4887_CR121","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jgh.14683","volume":"34","author":"H Watson","year":"2019","unstructured":"Watson H, Guevara M, Vilstrup H, Gin\u00e8s P (2019) Improvement of hyponatremia in cirrhosis is associated with improved complex information processing. J Gastroenterol Hepatol 34(11):1999\u20132003","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"4887_CR122","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/fcp.12340","volume":"32","author":"N Weiss","year":"2018","unstructured":"Weiss N, Tripon S, Lodey M, Guiller E, Junot H, Monneret D et al (2018) Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study. Fundam Clin Pharmacol 32(2):209\u2013215","journal-title":"Fundam Clin Pharmacol"},{"key":"4887_CR123","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11011-012-9336-4","volume":"28","author":"K Weissenborn","year":"2013","unstructured":"Weissenborn K (2013) Psychometric tests for diagnosing minimal hepatic encephalopathy. Metab Brain Dis 28:227\u2013229","journal-title":"Metab Brain Dis"},{"issue":"Suppl 1","key":"4887_CR124","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40265-018-1018-z","volume":"79","author":"K Weissenborn","year":"2019","unstructured":"Weissenborn K (2019) Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs 79(Suppl 1):5\u20139","journal-title":"Drugs"},{"key":"4887_CR125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104769","volume":"157","author":"MO Welcome","year":"2020","unstructured":"Welcome MO, Mastorakis NE (2020) Stress-induced blood brain barrier disruption: molecular mechanisms and signaling pathways. Pharmacol Res 157:104769","journal-title":"Pharmacol Res"},{"issue":"4","key":"4887_CR126","first-page":"323","volume":"7","author":"SP Wilkinson","year":"1995","unstructured":"Wilkinson SP (1995) GABA, benzodiazepines and hepatic encephalopathy. Eur J Gastroenterol Hepatol 7(4):323\u2013324","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"4887_CR127","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","volume":"8","author":"M Yan","year":"2023","unstructured":"Yan M, Man S, Sun B, Ma L, Guo L, Huang L et al (2023) Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduct Target Ther 8(1):443","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4887_CR128","volume":"3","author":"G Zaccherini","year":"2021","unstructured":"Zaccherini G, Weiss E, Moreau R (2021) Acute-on-chronic liver failure: definitions, pathophysiology and principles of treatment. JHEP Rep 3(1):100176","journal-title":"JHEP Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04887-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04887-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04887-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:42:02Z","timestamp":1778121722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04887-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":128,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4887"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04887-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animals or humans were used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}